Logo Logo
Hilfe
Hilfe
Switch Language to English

Scherberich, Jürgen E.; Gruber, Rudolf; Nockher, Wolfgang Andreas; Christensen, Erik Ilso; Schmitt, Hans; Herbst, Victor; Block, Matthias; Kaden, Jürgen und Schlumberger, Wolfgang (2018): Serum uromodulin-a marker of kidney function and renal parenchymal integrity. In: Nephrology Dialysis Transplantation, Bd. 33, Nr. 2: S. 284-295

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background. An ELISA to analyse uromodulin in human serum (sUmod) was developed, validated and tested for clinical applications. Methods. We assessed sUmod, a very stable antigen, in controls, patients with chronic kidney disease (CKD) stages 1-5, persons with autoimmune kidney diseases and recipients of a renal allograft by ELISA. Results. Median sUmod in 190 blood donors was 207 ng/mL (women: men, median 230 versus 188 ng/mL, P = 0.006). sUmod levels in 443 children were 193 ng/mL (median). sUmod was correlated with cystatin C (r(s) = -0.862), creatinine (r(s) = -0.802), blood urea nitrogen (BUN) (rs = -0.645) and estimated glomerular filtration rate (eGFR)-cystatin C (r(s) = 0.862). sUmod was lower in systemic lupus erythematosus-nephritis (median 101 ng/mL), phospholipase-A2 receptor-positive glomerulonephritis (median 83 ng/mL) and anti-glomerular basement membrane positive pulmorenal syndromes (median 37 ng/mL). Declining sUmod concentrations paralleled the loss of kidney function in 165 patients with CKD stages 1-5 with prominent changes in sUmod within the 'creatinine blind range' (71-106 mmol/L). Receiver-operating characteristic analysis between non-CKD and CKD-1 was superior for sUmod (AUC 0.90) compared with eGFR (AUC 0.39), cystatin C (AUC 0.39) and creatinine (AUC 0.27). sUmod rapidly recovered from 0 to 62 ng/mL (median) after renal transplantation in cases with immediate graft function and remained low in delayed graft function (21 ng/mL, median;day 5-9: relative risk 1.5-2.9, odds ratio 1.5-6.4). Immunogold labelling disclosed that Umod is transferred within cytoplasmic vesicles to both the apical and basolateral plasma membrane. Umod revealed a disturbed intracellular location in kidney injury. Conclusions. We conclude that sUmod is a novel sensitive kidney-specific biomarker linked to the structural integrity of the distal nephron and to renal function.

Dokument bearbeiten Dokument bearbeiten